Abstract:Background: CaMKII (Ca2+/calmodulin-dependent kinase II) plays a central role in cardiac ischemia/reperfusion (I/R) injury-an important therapeutic target for ischemic heart disease. In the heart, CaMKII-delta is the predominant isoform and further alternatively spliced into 11 variants. In humans, CaMKII-delta 9 and CaMKII-delta 3, the major cardiac splice variants, inversely regulate cardiomyocyte viability with the former pro-death and the latter pro-survival. However, it is unknown whether specific inhibition of the detrimental CaMKII-delta 9 prevents cardiac I/R injury and, if so, what is the underlying mechanism. Here, we aim to investigate the cardioprotective effect of specific CaMKII-delta 9 inhibition against myocardial I/R damage and determine the underlying mechanisms. Methods: The role and mechanism of CaMKII-delta 9 in cardiac I/R injury were investigated in mice in vivo, neonatal rat ventricular myocytes, and human embryonic stem cell-derived cardiomyocytes. Results: We demonstrate that CaMKII-delta 9 inhibition with knockdown or knockout of its feature exon, exon 16, protects the heart against I/R-elicited injury and subsequent heart failure. I/R-induced cardiac inflammation was also ameliorated by CaMKII-delta 9 inhibition, and compared with the previously well-studied CaMKII-delta 2, CaMKII-delta 9 overexpression caused more profound cardiac inflammation. Mechanistically, in addition to IKK beta (inhibitor of NF-kappa B [nuclear factor-kappa B] kinase subunit beta), CaMKII-delta 9, but not delta 2, directly interacted with I kappa B alpha (NF-kappa B inhibitor alpha) with its feature exon 13-16-17 combination and increased I kappa B alpha phosphorylation and consequently elicited more pronounced activation of NF-kappa B signaling and inflammatory response. Furthermore, the essential role of CaMKII-delta 9 in myocardial inflammation and damage was confirmed in human cardiomyocytes. Conclusions: We not only identified CaMKII-delta 9-IKK/I kappa B-NF-kappa B signaling as a new regulator of human cardiomyocyte inflammation but also demonstrated that specifically targeting CaMKII-delta 9, the most abundant CaMKII-delta splice variant in human heart, markedly suppresses I/R-induced cardiac NF-kappa B activation, inflammation, and injury and subsequently ameliorates myocardial remodeling and heart failure, providing a novel therapeutic strategy for various ischemic heart diseases.

Camkii Delta B Mediates Aberrant Ncx1 Expression And The Imbalance Of Ncx1/Serca In Transverse Aortic Constriction-Induced Failing Heart

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes.

Transcriptional Upregulation of Calcineurin Aβ by Endothelin-1 is Partially Mediated by Calcium/calmodulin-Dependent Protein Kinase IIδ3 in Rat Cardiomyocytes

Analysis of Na(+)/Ca (2+) Exchanger (NCX) Function and Current in Murine Cardiac Myocytes During Heart Failure.

CaMKII Inhibition in Heart Failure, Beneficial, Harmful, or Both.

Alterations of L-Type Calcium Current and Cardiac Function in Camkii Delta Knockout Mice

Abstract 18209: the Effect of CaMKIIdelta Knockout on Cardiac E-C Coupling in Heart Failure

CaMKII-9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure

CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure

CaMKII: do not work too hard in the failing heart.

Loss of Camk2n1 aggravates cardiac remodeling and malignant ventricular arrhythmia after myocardial infarction in mice via NLRP3 inflammasome activation

The δA isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the HDAC4-MEF2 signaling pathway.

Dynamin-2 Mediates Heart Failure By Modulating Ca2+-Dependent Cardiomyocyte Apoptosis

Ca2+/Calmodulin-dependent Protein Kinase II-dependent Remodeling of Ca2+ Current in Pressure Overload Heart Failure

CaMKII Exacerbates Heart Failure Progression by Activating Class I HDACs.

Elevated MCU Expression by CaMKIIδB Limits Pathological Cardiac Remodeling

Targeting CaMKII-9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation

Ca2+/calmodulin‐dependent kinase IIδC‐induced chronic heart failure does not depend on sarcoplasmic reticulum Ca2+ leak

Oxidative Activation of Ca(2+)/calmodulin-activated Kinase II Mediates ER Stress-Induced Cardiac Dysfunction and Apoptosis.

Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure